Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-DEspR monoclonal antibody targeted therapy and imaging for cancer and stroke

Anti-DEspR monoclonal antibody targeted therapy and imaging for cancer and stroke

US Patent 11236169 · Granted Feb 1, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treating NETosis and neutrophil activation2025
Methods for treating NETosis and neutrophil activation2025
Antibody specific for CD22 and methods of use thereof2024
Anti-kit antibodies and uses thereof2024
Anti-MET antibodies and methods of use thereof2024
Humanized antibodies against CEACAM12024
Polypeptides comprising a modified bacteriophage G3P amino acid sequence lacking2023
Compositions and methods for immunotherapy2023
Antibody therapies and methods for treating coronavirus infection2023
Antibody therapies and methods for treating coronavirus infection2023
Antibodies, uses thereof and conjugates thereof2022
Polynucleotides encoding humanized antibodies against CEACAM12022